Lincoln Pharmaceuticals informs about revised disclosures

04 May 2023 Evaluate
Lincoln Pharmaceuticals has informed that the exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mahendra Gulabdas Patel & PACs.

The above information is a part of company’s filings submitted to BSE.

Lincoln Pharma Share Price

561.65 -1.85 (-0.33%)
31-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1462.50
Dr. Reddys Lab 5784.50
Cipla 1451.25
Zydus Lifesciences 1001.15
Lupin 1587.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.